Paper38005384
Synthesis and Structural Characterization of Novel Dimers of Dipyridothiazine as Promising Antiproliferative Agents.
Martula E and 7 others. Molecules, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Synthesis and Structural Characterization of Novel Dimers of Dipyridothiazine as Promising Antiproliferative Agents. Papers, record 38005384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38005384
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthesis and Structural Characterization of Novel Dimers of Dipyridothiazine as Promising Antiproliferative Agents.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Magnetic Resonance Spectroscopy | |
| Drug Screening Assays, Antitumor | |
| Cell Proliferation | |
| Molecular Structure | |
| Structure-Activity Relationship |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PCN-1-041/K/2/F, PCN-1-043/K/2/F | Medical University of Silesia | PubMed | ||
| No. RW/45/2023 | Górnośląsko-Zagłębiowska Metropolis | PubMed | ||
| CERVIE : REIG-FAS -2023-005 | UCSI | PubMed |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17407813 | Synthesis and antitubercular activity of phenothiazines with reduced binding to dopamine and serotonin receptors. | Bioorg Med Chem Lett | 2007 | https://conductscience.org/library/papers/17407813 | PubMed |
| 2 | 34508254 | Cell cycle control in cancer. | Nat Rev Mol Cell Biol | 2022 | https://conductscience.org/library/papers/34508254 | PubMed |
| 3 | 32981100 | Small molecules regulating reactive oxygen species homeostasis for cancer therapy. | Med Res Rev | 2021 | https://conductscience.org/library/papers/32981100 | PubMed |
| 4 | 25462235 | Comparative (Q)SAR analysis of benzodiazepine derivatives with different biological activity. | Eur J Med Chem | 2015 | https://conductscience.org/library/papers/25462235 | PubMed |
| 5 | 29414306 | Repurposing psychiatric drugs as anti-cancer agents. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29414306 | PubMed |
| 6 | 20508288 | Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank. | Pharmacol Rep | 2010 | https://conductscience.org/library/papers/20508288 | PubMed |
| 7 | 36673955 | Efficacy of Topical Treatments for the Management of Symptomatic Oral Lichen Planus: A Systematic Review. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/36673955 | PubMed |
| 8 | 12626750 | Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12626750 | PubMed |
| 9 | 22580516 | Chemical structure of phenothiazines and their biological activity. | Pharmacol Rep | 2012 | https://conductscience.org/library/papers/22580516 | PubMed |
| 10 | 20232371 | Antioxidant activity of newly synthesized 2,7-diazaphenothiazines. | Arch Pharm (Weinheim) | 2010 | https://conductscience.org/library/papers/20232371 | PubMed |
| 11 | 27818603 | Synthesis, spectroscopic characterization, and anticancer activity of new 10-substituted 1,6-diazaphenothiazines. | Med Chem Res | 2016 | https://conductscience.org/library/papers/27818603 | PubMed |
| 12 | 32569821 | Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/32569821 | PubMed |
| 13 | 16772768 | Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents. | Am J Ther | 2006 | https://conductscience.org/library/papers/16772768 | PubMed |
| 14 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 15 | 37127180 | Phenothiazine derivatives and their impact on the necroptosis and necrosis processes. A review. | Toxicology | 2023 | https://conductscience.org/library/papers/37127180 | PubMed |
| 16 | 34687129 | Tryptophan and its metabolites in normal physiology and cancer etiology. | FEBS J | 2023 | https://conductscience.org/library/papers/34687129 | PubMed |
| 17 | 25750499 | Synthesis and selected immunological properties of 10-substituted 1,8-diazaphenothiazines. | Med Chem Res | 2015 | https://conductscience.org/library/papers/25750499 | PubMed |
| 18 | 29123378 | 10H-3,6-Diazaphenothiazine induces G2/M phase cell cycle arrest and caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through the regulation of NF-κB and (BIRC6-XIAP) complexes. | Drug Des Devel Ther | 2017 | https://conductscience.org/library/papers/29123378 | PubMed |
| 19 | 36534165 | Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer-a double-blind, randomized placebo-controlled clinical multicenter phase IV trial. | Support Care Cancer | 2022 | https://conductscience.org/library/papers/36534165 | PubMed |
| 20 | 26950280 | 3,6-Diazaphenothiazines as potential lead molecules - synthesis, characterization and anticancer activity. | J Enzyme Inhib Med Chem | 2016 | https://conductscience.org/library/papers/26950280 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42321356 | Based on artificial intelligence-assisted generation and in-depth in-silico evaluation of potential inhibitors targeting Stearoyl-CoA desaturase 1 (SCD-1). | Sci Rep | 2026 | https://conductscience.org/library/papers/42321356 | PubMed |
| 41897285 | New 1,2,3-Triazole and Dipyridothiazine Hybrids-Synthesis, Analysis, Cytotoxicity and Molecular Docking. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897285 | PubMed |
| 41751392 | Design, Synthesis, Analysis, and Cytotoxicity of Novel Heteroaryl Derivatives of Dipyridothiazines. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41751392 | PubMed |
| 39339271 | Analysis of Lipophilicity and Pharmacokinetic Parameters of Dipyridothiazine Dimers with Anticancer Potency. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339271 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38005384
GET https://conductscience.org/api/papers/v1/38005384/references?page=2